10x Genomics, Inc. (TXG) › Weighted Average Diluted Shares10x Genomics, Inc. (TXG) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2019-12-31: 39.09M2020-12-31: 101.15M2021-12-31: 110.35M2022-12-31: 113.86M2023-12-31: 117.17M2024-12-31: 120.45M2025-12-31: 124.75M124.75M2019-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31124.75M+3.6%2026-02-13From 2025-01-012024-12-31120.45M+2.8%2026-02-13From 2024-01-012023-12-31117.17M+2.9%2026-02-13From 2023-01-012022-12-31113.86M+3.2%2025-02-13From 2022-01-012021-12-31110.35M+9.1%2024-02-15From 2021-01-012020-12-31101.15M+158.8%2023-02-16From 2020-01-012019-12-3139.09M—2022-02-18From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)